Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis. - Wikidata - awgldk - TriplyDB

Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis.

Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis.

http://www.wikidata.org/entity/Q34768131

about

Molecular biology of lung cancer Somatic mutations affect key pathways in lung adenocarcinoma Surgical pathology of early stage non-small cell lung carcinoma The 2011 IASLC/ATS/ERS pulmonary adenocarcinoma classification: a landmark in personalized medicine for lung cancer management Staging lymph node metastases from lung cancer in the mediastinum Role of molecular studies in the diagnosis of lung adenocarcinoma Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma.International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma Proteasomal non-catalytic subunit PSMD2 as a potential therapeutic target in association with various clinicopathologic features in lung adenocarcinomas Lung cancer: prevalent trends & emerging concepts Pulmonary adenocarcinoma: a renewed entity in 2011 Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study.Utility of Genomic Analysis in Differentiating Synchronous and Metachronous Lung Adenocarcinomas from Primary Adenocarcinomas with Intrapulmonary Metastasis.Clinically relevant characterization of lung adenocarcinoma subtypes based on cellular pathways: an international validation study.Mapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicine.Prognostic factors in resected lung carcinomas.Differential expression of CRKL and AXL genes in lung adenocarcinoma subtypes according to the epidermal growth factor receptor and anaplastic lymphoma kinase gene status.Prognostic significance of grading in lung adenocarcinoma.Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR.Targeted Therapies in Lung Cancer.C4.4A as a biomarker in pulmonary adenocarcinoma and squamous cell carcinoma Recent advances and clinical implications of the micropapillary histological subtype in lung adenocarcinomas Should we continue to use the term non-small-cell lung cancer?Co-activation of epidermal growth factor receptor and c-MET defines a distinct subset of lung adenocarcinomas.Tgf-beta signaling pathway in lung adenocarcinoma invasion.Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification.Implementing the new IASLC/ATS/ERS classification of lung adenocarcinomas: results from international and Chinese cohorts.Prognostic implication of predominant histologic subtypes of lymph node metastases in surgically resected lung adenocarcinoma Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer.Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model.Correlation of EGFR mutation and histological subtype according to the IASLC/ATS/ERS classification of lung adenocarcinoma.Differences in the prognosis of resected lung adenocarcinoma according to the histological subtype: a retrospective analysis of Japanese lung cancer registry data.Micropapillary lung adenocarcinoma: EGFR, K-ras, and BRAF mutational profile.Correlation of histological components with tumor invasion in pulmonary adenocarcinoma A comprehensive comparative analysis of the histomorphological features of ALK-rearranged lung adenocarcinoma based on driver oncogene mutations: frequent expression of epithelial-mesenchymal transition markers than other genotype RSK1 activation promotes invasion in nodular melanoma.The morphological and molecular diagnosis of lung cancer.The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype.

P2860

Q24606677-3262758E-C981-4C9D-AD96-8B25F74D7E25 Q24648102-F7F87830-BA82-4D10-A25B-798D08695532 Q26739713-30F3BCA6-06F6-4BDA-9480-5AA89CBA94C8 Q26851443-22B8F534-952F-4B56-AC94-322A145DC466 Q26863443-572ED4F1-6447-4CB3-B456-F9C6759FBB5F Q27023212-2F453661-E91B-4F4E-8E59-3E029035ECCF Q27851458-A2F7BC88-DD23-4A47-B521-A7BE375BE91D Q28303718-764F8E2E-D03B-4756-BED9-23C2044FD2F4 Q28308220-87DF4D68-87BE-4DD6-AD93-97BF8ED6834A Q28392286-95EB7D83-B2BC-496D-891B-9766779A364D Q28395348-2D4CDC40-E9CD-4080-954E-7C0DBC3F9475 Q28730029-3C618B5A-E33B-43D2-A115-5E2D644FF6F8 Q33536148-5B331BA7-88D7-4D2E-A16F-B2EBD0F1D6F3 Q33607511-70113D26-0BE6-49F9-B600-A73FEE2126FB Q33641395-1742193D-9967-4E75-B6C1-C08580DAD1BC Q33688542-275148B6-1A39-4CE6-A561-DC04D710306D Q33697964-1600C51A-C348-4124-90A5-17558E778364 Q33733522-A751C543-57AE-4DBD-A717-E178F19F4CA7 Q33758236-FE4AC087-41C8-4C47-9DAF-92587CB34FD4 Q33833942-173EAD9B-DE14-4517-876A-69AF697BE2A5 Q33847505-18747770-33F3-41E6-AEAB-A050E5B70B64 Q34030379-B90111A7-57ED-4F19-B6D6-522A4AF2FD0B Q34031219-3A29BE35-EF69-4BB9-B852-A514FDC251D6 Q34141249-B64B3A1E-7406-4535-9F51-069F4B17E18C Q34143340-A65E72ED-BB2E-493D-AA2B-6DBED9A33897 Q34254343-6B53AF95-C71A-4DE4-897D-1C271A36B726 Q34356297-5623D83C-B282-42EA-83E6-83D53857DDE6 Q34404209-3642D8E8-1588-4397-BD30-4471924E5AF5 Q34404229-6772FD1A-96E5-478B-8352-2C61B00B9BC0 Q34406294-AFEF808F-877B-4092-89BD-4177E04053D5 Q34467915-96411E85-C0BC-484B-AF73-62548824A531 Q34633885-61AD78C7-79F7-4B2B-B03B-DD2787CAD5AB Q34732930-70253F98-5E98-48FD-B40C-BF3A9DEF85BD Q34752733-5ACDE44D-1741-4255-958B-A61B071FC334 Q34975977-C9D1A1D6-01A3-409C-A587-1F295B04E23C Q34994833-89858802-FFB5-45E2-BD27-9866494C28CA Q35032336-19796523-1070-4C53-8553-769E9086011D Q35143744-500C10D8-9DA2-4998-8A32-237A0994ED4F Q35186535-604B3CD8-1855-45C9-BA00-75596EF35A82 Q35219157-4D54F915-C775-4FE2-8603-3425DDFB87B3

P2860

Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis.

http://www.wikidata.org/entity/Q34768131

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Lung adenocarcinoma: modificat ...... and gene expression analysis.

@ast

Lung adenocarcinoma: modificat ...... and gene expression analysis.

@en

Lung adenocarcinoma: modificat ...... and gene expression analysis.

@nl

type

label

Lung adenocarcinoma: modificat ...... and gene expression analysis.

@ast

Lung adenocarcinoma: modificat ...... and gene expression analysis.

@en

Lung adenocarcinoma: modificat ...... and gene expression analysis.

@nl

prefLabel

Lung adenocarcinoma: modificat ...... and gene expression analysis.

@ast

Lung adenocarcinoma: modificat ...... and gene expression analysis.

@en

Lung adenocarcinoma: modificat ...... and gene expression analysis.

@nl

P1433

Q34768131-5E40A456-6A09-4431-88DF-BAB0E976DFD9

P1476

Q34768131-84C5B0BB-8AC4-4388-9168-60745FB15CD3

P2093

Q34768131-236F04BA-07FC-4A09-BBC7-2D250B1A5250

Q34768131-23EDED2A-B4E8-40D9-8C55-F2B9DBB00CCB

Q34768131-28098524-818A-46CE-BF73-DA13E070E664

Q34768131-2F1AB837-7BC0-452E-BBAF-EE15F565DA90

Q34768131-3BF50675-A6E0-4FBA-85C9-A67C2C3D7755

Q34768131-D8C6EDB0-BE37-4409-BC01-8F11E11DF0D1

Q34768131-DA125423-4203-493D-9C8D-EBD0F702CD28

Q34768131-EFDEBDFA-26F6-4049-8230-BAFB5E209B64

P304

Q34768131-E566646C-AC93-4C49-B1E5-1F1E17C4F9D7

P31

Q34768131-A7F6F7A3-3520-48C5-898C-D50F130333CF

P356

Q34768131-64078F79-22A5-4F58-9939-5701DB0DF167

P407

Q34768131-5969B801-D4ED-4781-9307-1B4D16692924

P433

Q34768131-786A9CAA-3DDE-4315-8C1B-EC6E5EBD7101

P478

Q34768131-585C16F5-0A63-4528-AED1-149947CC5A82

P577

Q34768131-6D963015-77B1-459B-9EC1-2EB0AE5CFD3C

P698

Q34768131-8FBC2507-05A3-43FE-9385-E5A5C1A7E0C2

P921

Q34768131-3BA8A46B-446D-4F04-96D5-E296784AF76D

Q34768131-B3344C28-C18F-4E42-84DE-B7CC32350E83

P356

PAS.0B013E31815CB162

P1433

The American Journal of Surgical Pathology

P1476

Lung adenocarcinoma: modificat ...... and gene expression analysis.

@en

P2093

Gregory J Riely

http://www.w3.org/2001/XMLSchema#string

Janos Szoke

http://www.w3.org/2001/XMLSchema#string

Mark G Kris

http://www.w3.org/2001/XMLSchema#string

Noriko Motoi

http://www.w3.org/2001/XMLSchema#string

Valerie W Rusch

http://www.w3.org/2001/XMLSchema#string

Venkatraman E Seshan

http://www.w3.org/2001/XMLSchema#string

William D Travis

http://www.w3.org/2001/XMLSchema#string

William L Gerald

http://www.w3.org/2001/XMLSchema#string

P304

810-827

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/PAS.0B013E31815CB162

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18391747

http://www.w3.org/2001/XMLSchema#string

P921

Alþjóðaheilbrigðismálastofnunin